메뉴 건너뛰기




Volumn 110, Issue 2, 2015, Pages

Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix

Author keywords

Cardiac remodelling; Extracellular matrix; Glucagon like peptide 1; Inflammation; Myocardial infarction

Indexed keywords

EXENDIN 4; FIBRONECTIN; GLUCAGON LIKE PEPTIDE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PROTEIN KINASE B; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA3; PEPTIDE; VENOM;

EID: 84935009269     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-015-0476-7     Document Type: Article
Times cited : (58)

References (62)
  • 1
    • 64749102956 scopus 로고    scopus 로고
    • Diabetes: a cardiac condition manifesting as hyperglycemia
    • PID: 18996825
    • Bell DS (2008) Diabetes: a cardiac condition manifesting as hyperglycemia. Endocr Pract 14:924–932. doi:10.4158/EP.14.7.924
    • (2008) Endocr Pract , vol.14 , pp. 924-932
    • Bell, D.S.1
  • 2
    • 80051952268 scopus 로고    scopus 로고
    • Implications of new hypertension guidelines in the United States
    • COI: 1:CAS:528:DC%2BC3MXhtVaksrfJ, PID: 21768528
    • Bertoia ML, Waring ME, Gupta PS, Roberts MB, Eaton CB (2011) Implications of new hypertension guidelines in the United States. Hypertension 58:361–366. doi:10.1161/HYPERTENSIONAHA.111.175463
    • (2011) Hypertension , vol.58 , pp. 361-366
    • Bertoia, M.L.1    Waring, M.E.2    Gupta, P.S.3    Roberts, M.B.4    Eaton, C.B.5
  • 3
    • 84901831627 scopus 로고    scopus 로고
    • Cardiovascular remodelling in coronary artery disease and heart failure
    • PID: 24831770
    • Heusch G, Libby P, Gersh B, Yellon D, Bohm M, Lopaschuk G, Opie L (2014) Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383:1933–1943. doi:10.1016/S0140-6736(14)60107-0
    • (2014) Lancet , vol.383 , pp. 1933-1943
    • Heusch, G.1    Libby, P.2    Gersh, B.3    Yellon, D.4    Bohm, M.5    Lopaschuk, G.6    Opie, L.7
  • 4
    • 84875987216 scopus 로고    scopus 로고
    • Heart Failure. JACC
    • Braunwald E (2013) Heart Failure. JACC. Heart Fail 1:1–20. doi:10.1016/j.jchf.2012.10.002
    • (2013) Heart Fail , vol.1 , pp. 1-20
    • Braunwald, E.1
  • 5
    • 84890910451 scopus 로고    scopus 로고
    • National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998–2010
    • PID: 24190958
    • Chen J, Hsieh AF, Dharmarajan K, Masoudi FA, Krumholz HM (2013) National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998–2010. Circulation 128:2577–2584. doi:10.1161/CIRCULATIONAHA.113.003668
    • (2013) Circulation , vol.128 , pp. 2577-2584
    • Chen, J.1    Hsieh, A.F.2    Dharmarajan, K.3    Masoudi, F.A.4    Krumholz, H.M.5
  • 6
    • 70350341465 scopus 로고    scopus 로고
    • Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?
    • COI: 1:CAS:528:DC%2BD1MXhsVKmu7%2FE, PID: 19681866
    • Grieve DJ, Cassidy RS, Green BD (2009) Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control? Br J Pharmacol 157:1340–1351. doi:10.1111/j.1476-5381.2009.00376.x
    • (2009) Br J Pharmacol , vol.157 , pp. 1340-1351
    • Grieve, D.J.1    Cassidy, R.S.2    Green, B.D.3
  • 7
    • 84920778263 scopus 로고    scopus 로고
    • Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes
    • COI: 1:CAS:528:DC%2BC2MXks1Gisw%3D%3D, PID: 25231355
    • Tate M, Chong A, Robinson E, Green BD, Grieve DJ (2015) Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes. Br J Pharmacol 172:721–736. doi:10.1111/bph.12943
    • (2015) Br J Pharmacol , vol.172 , pp. 721-736
    • Tate, M.1    Chong, A.2    Robinson, E.3    Green, B.D.4    Grieve, D.J.5
  • 8
    • 43249089631 scopus 로고    scopus 로고
    • Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways
    • COI: 1:CAS:528:DC%2BD1cXltFyltrY%3D, PID: 18427132
    • Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ, Husain M (2008) Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways. Circulation 117:2340–2350. doi:10.1161/CIRCULATIONAHA.107.739938
    • (2008) Circulation , vol.117 , pp. 2340-2350
    • Ban, K.1    Noyan-Ashraf, M.H.2    Hoefer, J.3    Bolz, S.S.4    Drucker, D.J.5    Husain, M.6
  • 9
    • 52049093652 scopus 로고    scopus 로고
    • Grieve DJ (2008) GLP-1 and related peptides cause concentration-dependent relaxation of rat aorta through a pathway involving KATP and cAMP
    • COI: 1:CAS:528:DC%2BD1cXhtFCks7bI, PID: 18708025
    • Green BD, Hand KV, Dougan JE, McDonnell BM, Cassidy RS (2008) Grieve DJ (2008) GLP-1 and related peptides cause concentration-dependent relaxation of rat aorta through a pathway involving KATP and cAMP. Arch Biochem Biophys 478:136–142. doi:10.1016/j.abb.2008.08.001
    • (2008) Arch Biochem Biophys , vol.478 , pp. 136-142
    • Green, B.D.1    Hand, K.V.2    Dougan, J.E.3    McDonnell, B.M.4    Cassidy, R.S.5
  • 11
    • 0035980166 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes
    • COI: 1:STN:280:DC%2BD3MvpvFKktA%3D%3D, PID: 11532906
    • Vila Petroff MG, Egan JM, Wang X, Sollott SJ (2001) Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circ Res 89:445–452. doi:10.1161/hh1701.095716
    • (2001) Circ Res , vol.89 , pp. 445-452
    • Vila Petroff, M.G.1    Egan, J.M.2    Wang, X.3    Sollott, S.J.4
  • 13
    • 84903807727 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 (7-36) but not (9-36) augments cardiac output during myocardial ischemia via a Frank-Starling mechanism
    • PID: 25005062
    • Goodwill A, Tune J, Noblet J, Conteh A, Sassoon D, Casalini E, Mather K (2014) Glucagon-like peptide-1 (7-36) but not (9-36) augments cardiac output during myocardial ischemia via a Frank-Starling mechanism. Basic Res Cardiol 109:426. doi:10.1007/s00395-014-0426-9
    • (2014) Basic Res Cardiol , vol.109 , pp. 426
    • Goodwill, A.1    Tune, J.2    Noblet, J.3    Conteh, A.4    Sassoon, D.5    Casalini, E.6    Mather, K.7
  • 14
    • 4344605042 scopus 로고    scopus 로고
    • Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy
    • COI: 1:CAS:528:DC%2BD2cXms1OgtLw%3D, PID: 15313949
    • Nikolaidis LA, Elahi D, Hentosz T, Doverspike A, Huerbin R, Zourelias L, Stolarski C, Shen YT, Shannon RP (2004) Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy. Circulation 110:955–961. doi:10.1161/01.CIR.0000139339.85840.DD
    • (2004) Circulation , vol.110 , pp. 955-961
    • Nikolaidis, L.A.1    Elahi, D.2    Hentosz, T.3    Doverspike, A.4    Huerbin, R.5    Zourelias, L.6    Stolarski, C.7    Shen, Y.T.8    Shannon, R.P.9
  • 15
    • 64649102619 scopus 로고    scopus 로고
    • GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice
    • COI: 1:CAS:528:DC%2BD1MXktleiu7o%3D, PID: 19151200
    • Noyan-Ashraf MH, Momen MA, Ban K, Sadi AM, Zhou YQ, Riazi AM, Baggio LL, Henkelman RM, Husain M, Drucker DJ (2009) GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes 58:975–983. doi:10.2337/db08-1193
    • (2009) Diabetes , vol.58 , pp. 975-983
    • Noyan-Ashraf, M.H.1    Momen, M.A.2    Ban, K.3    Sadi, A.M.4    Zhou, Y.Q.5    Riazi, A.M.6    Baggio, L.L.7    Henkelman, R.M.8    Husain, M.9    Drucker, D.J.10
  • 16
    • 58949102483 scopus 로고    scopus 로고
    • Chronic glucagon-like peptide-1 (GLP-1) infusion sustains LV systolic function and prolongs survival in the spontaneously hypertensive-heart failure prone rat
    • COI: 1:CAS:528:DC%2BD1cXhtV2jsrzF, PID: 19727407
    • Poornima I, Brown S, Bhashyam S, Parikh P, Bolukoglu H, Shannon RP (2008) Chronic glucagon-like peptide-1 (GLP-1) infusion sustains LV systolic function and prolongs survival in the spontaneously hypertensive-heart failure prone rat. Circ Heart Fail 1:153–160. doi:10.1161/CIRCHEARTFAILURE.108.766402
    • (2008) Circ Heart Fail , vol.1 , pp. 153-160
    • Poornima, I.1    Brown, S.2    Bhashyam, S.3    Parikh, P.4    Bolukoglu, H.5    Shannon, R.P.6
  • 17
    • 77951168113 scopus 로고    scopus 로고
    • Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes following myocardial infarction in mice
    • COI: 1:CAS:528:DC%2BC3cXltFSmtLk%3D, PID: 20097729
    • Sauve M, Ban K, Momen MA, Zhou YQ, Henkelman RM, Husain M, Drucker DJ (2010) Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes following myocardial infarction in mice. Diabetes 59:1063–1073. doi:10.2337/db09-0955
    • (2010) Diabetes , vol.59 , pp. 1063-1073
    • Sauve, M.1    Ban, K.2    Momen, M.A.3    Zhou, Y.Q.4    Henkelman, R.M.5    Husain, M.6    Drucker, D.J.7
  • 18
    • 33845293219 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure
    • COI: 1:CAS:528:DC%2BD28XhtlaqsrzK, PID: 17174230
    • Sokos GG, Nikolaidis LA, Mankad S, Elahi D, Shannon RP (2006) Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. J Card Fail 12:694–699. doi:10.1016/j.cardfail.2006.08.211
    • (2006) J Card Fail , vol.12 , pp. 694-699
    • Sokos, G.G.1    Nikolaidis, L.A.2    Mankad, S.3    Elahi, D.4    Shannon, R.P.5
  • 19
    • 12144260853 scopus 로고    scopus 로고
    • Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury
    • COI: 1:CAS:528:DC%2BD2MXhtVWju7k%3D, PID: 15616022
    • Bose AK, Mocanu MM, Carr RD, Brand CL, Yellon DM (2005) Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes 54:146–151. doi:10.2337/diabetes.54.1.146
    • (2005) Diabetes , vol.54 , pp. 146-151
    • Bose, A.K.1    Mocanu, M.M.2    Carr, R.D.3    Brand, C.L.4    Yellon, D.M.5
  • 21
    • 78149493266 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure
    • PID: 21080957
    • Liu Q, Anderson C, Broyde A, Polizzi C, Fernandez R, Baron A, Parkes D (2010) Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure. Cardiovasc Diabetol 9:76. doi:10.1186/1475-2840-9-76
    • (2010) Cardiovasc Diabetol , vol.9 , pp. 76
    • Liu, Q.1    Anderson, C.2    Broyde, A.3    Polizzi, C.4    Fernandez, R.5    Baron, A.6    Parkes, D.7
  • 22
    • 1442311383 scopus 로고    scopus 로고
    • Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion
    • COI: 1:CAS:528:DC%2BD2cXhsFeisbY%3D, PID: 14981009
    • Nikolaidis LA, Mankad S, Sokos GG, Miske G, Shah A, Elahi D, Shannon RP (2004) Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation 109:962–965. doi:10.1161/01.CIR.0000120505.91348.58
    • (2004) Circulation , vol.109 , pp. 962-965
    • Nikolaidis, L.A.1    Mankad, S.2    Sokos, G.G.3    Miske, G.4    Shah, A.5    Elahi, D.6    Shannon, R.P.7
  • 23
    • 84908042187 scopus 로고    scopus 로고
    • Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium
    • COI: 1:CAS:528:DC%2BC2cXitVWksrjI, PID: 25117407
    • DeNicola M, Du J, Wang Z, Yano N, Zhang L, Wang Y, Qin G, Zhuang S, Zhao TC (2014) Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium. Am J Physiol Endocrinol Metab 307:E630–E643. doi:10.1152/ajpendo.00109.2014
    • (2014) Am J Physiol Endocrinol Metab , vol.307 , pp. 630-643
    • DeNicola, M.1    Du, J.2    Wang, Z.3    Yano, N.4    Zhang, L.5    Wang, Y.6    Qin, G.7    Zhuang, S.8    Zhao, T.C.9
  • 24
    • 84904283347 scopus 로고    scopus 로고
    • Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection
    • COI: 1:CAS:528:DC%2BC2cXosl2jtbo%3D, PID: 25061556
    • Ussher JR, Baggio LL, Campbell JE, Mulvihill EE, Kim M, Kabir MG, Cao X, Baranek BM, Stoffers DA, Seeley RJ, Drucker DJ (2014) Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection. Mol Metab 3:507–517. doi:10.1016/j.molmet.2014.04.009
    • (2014) Mol Metab , vol.3 , pp. 507-517
    • Ussher, J.R.1    Baggio, L.L.2    Campbell, J.E.3    Mulvihill, E.E.4    Kim, M.5    Kabir, M.G.6    Cao, X.7    Baranek, B.M.8    Stoffers, D.A.9    Seeley, R.J.10    Drucker, D.J.11
  • 25
    • 0041375468 scopus 로고    scopus 로고
    • Regulation of ERK1 and ERK2 by glucose and peptide hormones in pancreatic β cells
    • COI: 1:CAS:528:DC%2BD3sXms1amtrg%3D, PID: 12783880
    • Arnette D, Gibson TB, Lawrence MC, January B, Khoo S, McGlynn K, Vanderbilt CA, Cobb MH (2003) Regulation of ERK1 and ERK2 by glucose and peptide hormones in pancreatic β cells. J Biol Chem 278:32517–32525. doi:10.1074/jbc.M301174200
    • (2003) J Biol Chem , vol.278 , pp. 32517-32525
    • Arnette, D.1    Gibson, T.B.2    Lawrence, M.C.3    January, B.4    Khoo, S.5    McGlynn, K.6    Vanderbilt, C.A.7    Cobb, M.H.8
  • 26
    • 70349334516 scopus 로고    scopus 로고
    • Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson’s disease
    • COI: 1:CAS:528:DC%2BD1MXhtFahtLnF, PID: 19570816
    • Kim S, Moon M, Park S (2009) Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson’s disease. J Endocrinol 202:431–439. doi:10.1677/JOE-09-0132
    • (2009) J Endocrinol , vol.202 , pp. 431-439
    • Kim, S.1    Moon, M.2    Park, S.3
  • 27
    • 0032941026 scopus 로고    scopus 로고
    • Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in chinese hamster ovary cells
    • COI: 1:CAS:528:DyaK1MXhsFCjt7c%3D, PID: 10067836
    • Montrose-Rafizadeh C, Avdonin P, Garant MJ, Rodgers BD, Kole S, Yang H, Levine MA, Schwindinger W, Bernier M (1999) Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in chinese hamster ovary cells. Endocrinology 140:1132–1140. doi:10.1210/endo.140.3.6550
    • (1999) Endocrinology , vol.140 , pp. 1132-1140
    • Montrose-Rafizadeh, C.1    Avdonin, P.2    Garant, M.J.3    Rodgers, B.D.4    Kole, S.5    Yang, H.6    Levine, M.A.7    Schwindinger, W.8    Bernier, M.9
  • 28
    • 34047205064 scopus 로고    scopus 로고
    • Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice
    • COI: 1:CAS:528:DC%2BD2sXkslSrsb8%3D, PID: 17360951
    • Park CW, Kim HW, Ko SH, Lim JH, Ryu GR, Chung HW, Han SW, Shin SJ, Bang BK, Breyer MD, Chang YS (2007) Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice. J Am Soc Nephrol 18:1227–1238. doi:10.1681/ASN.2006070778
    • (2007) J Am Soc Nephrol , vol.18 , pp. 1227-1238
    • Park, C.W.1    Kim, H.W.2    Ko, S.H.3    Lim, J.H.4    Ryu, G.R.5    Chung, H.W.6    Han, S.W.7    Shin, S.J.8    Bang, B.K.9    Breyer, M.D.10    Chang, Y.S.11
  • 29
    • 77957678974 scopus 로고    scopus 로고
    • Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: potential therapeutic benefits in diabetic patients
    • COI: 1:CAS:528:DC%2BC3cXht1WltrrE, PID: 20635178
    • Pugazhenthi U, Velmurugan K, Tran A, Mahaffey G, Pugazhenthi S (2010) Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: potential therapeutic benefits in diabetic patients. Diabetologia 53:2357–2368. doi:10.1007/s00125-010-1849-y
    • (2010) Diabetologia , vol.53 , pp. 2357-2368
    • Pugazhenthi, U.1    Velmurugan, K.2    Tran, A.3    Mahaffey, G.4    Pugazhenthi, S.5
  • 30
    • 84909955874 scopus 로고    scopus 로고
    • The GLP-1 analogue liraglutide protects cardiomyocytes from high glucose-induced apoptosis by activating the Epac-1/Akt pathway
    • COI: 1:CAS:528:DC%2BC2cXhsl2nsrrL, PID: 25140997
    • Wu XM, Ou QY, Zhao W, Liu J, Zhang H (2014) The GLP-1 analogue liraglutide protects cardiomyocytes from high glucose-induced apoptosis by activating the Epac-1/Akt pathway. Exp Clin Endocrinol Diabetes 122:608–614. doi:10.1055/s-0034-1384584
    • (2014) Exp Clin Endocrinol Diabetes , vol.122 , pp. 608-614
    • Wu, X.M.1    Ou, Q.Y.2    Zhao, W.3    Liu, J.4    Zhang, H.5
  • 31
    • 38549128215 scopus 로고    scopus 로고
    • Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction
    • COI: 1:CAS:528:DC%2BD1cXmt1OhtA%3D%3D, PID: 18180403
    • Looi YH, Grieve DJ, Siva A, Walker SJ, Anilkumar N, Cave AC, Marber M, Monaghan MJ, Shah AM (2008) Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension 51:319–325. doi:10.1161/HYPERTENSIONAHA.107.101980
    • (2008) Hypertension , vol.51 , pp. 319-325
    • Looi, Y.H.1    Grieve, D.J.2    Siva, A.3    Walker, S.J.4    Anilkumar, N.5    Cave, A.C.6    Marber, M.7    Monaghan, M.J.8    Shah, A.M.9
  • 32
    • 33745937115 scopus 로고    scopus 로고
    • 8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta cell function after 3 weeks daily administration in obese diabetic (ob/ob) mice
    • COI: 1:CAS:528:DC%2BD28XnslOltL8%3D, PID: 16648370
    • 8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta cell function after 3 weeks daily administration in obese diabetic (ob/ob) mice. J Pharmacol Exp Ther 318:914–921. doi:10.1124/jpet.105.097824
    • (2006) J Pharmacol Exp Ther , vol.318 , pp. 914-921
    • Green, B.D.1    Lavery, K.S.2    Irwin, N.3    O’Harte, F.P.4    Harriott, P.5    Greer, B.6    Bailey, C.J.7    Flatt, P.R.8
  • 33
    • 65949093707 scopus 로고    scopus 로고
    • Modulation of the caveolin-3 localization to caveolae and STAT3 to mitochondria by catecholamine-induced cardiac hypertrophy in H9c2 cardiomyocytes
    • COI: 1:CAS:528:DC%2BD1MXlslOmsLc%3D, PID: 19299911
    • Jeong K, Kwon H, Min C, Pak Y (2009) Modulation of the caveolin-3 localization to caveolae and STAT3 to mitochondria by catecholamine-induced cardiac hypertrophy in H9c2 cardiomyocytes. Exp Mol Med 41:226–235. doi:10.3858/emm.2009.41.4.025
    • (2009) Exp Mol Med , vol.41 , pp. 226-235
    • Jeong, K.1    Kwon, H.2    Min, C.3    Pak, Y.4
  • 34
    • 0037311110 scopus 로고    scopus 로고
    • Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis
    • COI: 1:CAS:528:DC%2BD3sXnvV2gsg%3D%3D, PID: 12527808
    • Kim Y, Ma AG, Kitta K, Fitch SN, Ikeda T, Ihara Y, Simon AR, Evans T, Suzuki YJ (2003) Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis. Mol Pharmacol 63:368–377. doi:10.1124/mol.63.2.368
    • (2003) Mol Pharmacol , vol.63 , pp. 368-377
    • Kim, Y.1    Ma, A.G.2    Kitta, K.3    Fitch, S.N.4    Ikeda, T.5    Ihara, Y.6    Simon, A.R.7    Evans, T.8    Suzuki, Y.J.9
  • 37
    • 73249126900 scopus 로고    scopus 로고
    • Inhibition of collagen fibrillogenesis by cells expressing soluble extracellular domains of DDR1 and DDR2
    • COI: 1:CAS:528:DC%2BC3cXjt12kuw%3D%3D, PID: 19900459
    • Flynn LA, Blissett AR, Calomeni EP, Agarwal G (2010) Inhibition of collagen fibrillogenesis by cells expressing soluble extracellular domains of DDR1 and DDR2. J Mol Biol 395:533–543. doi:10.1016/j.jmb.2009.10.073
    • (2010) J Mol Biol , vol.395 , pp. 533-543
    • Flynn, L.A.1    Blissett, A.R.2    Calomeni, E.P.3    Agarwal, G.4
  • 38
    • 77955270565 scopus 로고    scopus 로고
    • Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy
    • COI: 1:CAS:528:DC%2BC3cXpvV2gurk%3D, PID: 20488188
    • Haudek SB, Cheng J, Du J, Wang Y, Hermosillo-Rodriguez J, Trial J, Taffet GE, Entman ML (2010) Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. J Mol Cell Cardiol 49:499–507. doi:10.1016/j.yjmcc.2010.05.005
    • (2010) J Mol Cell Cardiol , vol.49 , pp. 499-507
    • Haudek, S.B.1    Cheng, J.2    Du, J.3    Wang, Y.4    Hermosillo-Rodriguez, J.5    Trial, J.6    Taffet, G.E.7    Entman, M.L.8
  • 39
    • 84905109590 scopus 로고    scopus 로고
    • Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart
    • COI: 1:CAS:528:DC%2BC2cXhtlKksL7M, PID: 24899689
    • Lal H, Ahmad F, Zhou J, Yu JE, Vagnozzi RJ, Guo Y, Yu D, Tsai EJ, Woodgett J, Gao E, Force T (2014) Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart. Circulation 130:419–430. doi:10.1161/CIRCULATIONAHA.113.008364
    • (2014) Circulation , vol.130 , pp. 419-430
    • Lal, H.1    Ahmad, F.2    Zhou, J.3    Yu, J.E.4    Vagnozzi, R.J.5    Guo, Y.6    Yu, D.7    Tsai, E.J.8    Woodgett, J.9    Gao, E.10    Force, T.11
  • 40
    • 40349098058 scopus 로고    scopus 로고
    • Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis
    • COI: 1:CAS:528:DC%2BD1cXislSjur4%3D, PID: 18204489
    • Sugden PH, Fuller SJ, Weiss SC, Clerk A (2008) Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol 153(Suppl 1):S137–S153. doi:10.1038/sj.bjp.0707659
    • (2008) Br J Pharmacol , vol.153 , pp. 137-153
    • Sugden, P.H.1    Fuller, S.J.2    Weiss, S.C.3    Clerk, A.4
  • 41
    • 77951498855 scopus 로고    scopus 로고
    • Adaptive and maladaptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading
    • COI: 1:CAS:528:DC%2BD1MXhtlyqsLfP, PID: 19919989
    • Divakaran V, Adrogue J, Ishiyama M, Entman ML, Haudek S, Sivasubramanian N, Mann DL (2009) Adaptive and maladaptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading. Circ Heart Fail 2:633–642. doi:10.1161/CIRCHEARTFAILURE.108.823070
    • (2009) Circ Heart Fail , vol.2 , pp. 633-642
    • Divakaran, V.1    Adrogue, J.2    Ishiyama, M.3    Entman, M.L.4    Haudek, S.5    Sivasubramanian, N.6    Mann, D.L.7
  • 42
    • 33646076196 scopus 로고    scopus 로고
    • GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation
    • COI: 1:CAS:528:DC%2BD28Xht1Cmurs%3D, PID: 16397142
    • Xu J, Kimball TR, Lorenz JN, Brown DA, Bauskin AR, Klevitsky R, Hewett TE, Breit SN, Molkentin JD (2006) GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 98:342–350. doi:10.1161/01.RES.0000202804.84885.d0
    • (2006) Circ Res , vol.98 , pp. 342-350
    • Xu, J.1    Kimball, T.R.2    Lorenz, J.N.3    Brown, D.A.4    Bauskin, A.R.5    Klevitsky, R.6    Hewett, T.E.7    Breit, S.N.8    Molkentin, J.D.9
  • 46
    • 77951812608 scopus 로고    scopus 로고
    • The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA
    • COI: 1:CAS:528:DC%2BC3cXmt1Kmurk%3D, PID: 20207816
    • Ye Y, Keyes KT, Zhang C, Perez-Polo JR, Lin Y, Birnbaum Y (2010) The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA. Am J Physiol Heart Circ Physiol 298:H1454–H1465. doi:10.1152/ajpheart.00867.2009
    • (2010) Am J Physiol Heart Circ Physiol , vol.298 , pp. 1454-1465
    • Ye, Y.1    Keyes, K.T.2    Zhang, C.3    Perez-Polo, J.R.4    Lin, Y.5    Birnbaum, Y.6
  • 47
    • 32644448320 scopus 로고    scopus 로고
    • The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy
    • COI: 1:CAS:528:DC%2BD28XhsFCqt74%3D, PID: 16487830
    • Asbun J, Villarreal FJ (2006) The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 47:693–700. doi:10.1016/j.jacc.2005.09.050
    • (2006) J Am Coll Cardiol , vol.47 , pp. 693-700
    • Asbun, J.1    Villarreal, F.J.2
  • 48
    • 38149083367 scopus 로고    scopus 로고
    • Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart
    • COI: 1:CAS:528:DC%2BD1cXosFKnsw%3D%3D, PID: 17976835
    • Sonne DP, Engstrom T, Treiman M (2008) Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart. Regul Pept 146:243–249. doi:10.1016/j.regpep.2007.10.001
    • (2008) Regul Pept , vol.146 , pp. 243-249
    • Sonne, D.P.1    Engstrom, T.2    Treiman, M.3
  • 49
    • 84911411150 scopus 로고    scopus 로고
    • Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction
    • PID: 25248433
    • Kain V, Prabhu S, Halade G (2014) Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction. Basic Res Cardiol 109:444. doi:10.1007/s00395-014-0444-7
    • (2014) Basic Res Cardiol , vol.109 , pp. 444
    • Kain, V.1    Prabhu, S.2    Halade, G.3
  • 50
    • 59849089688 scopus 로고    scopus 로고
    • IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR
    • COI: 1:CAS:528:DC%2BD1MXntFahuw%3D%3D, PID: 19096025
    • Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R (2009) IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res 104:e9–e18. doi:10.1161/CIRCRESAHA.108.188243
    • (2009) Circ Res , vol.104 , pp. 9-18
    • Krishnamurthy, P.1    Rajasingh, J.2    Lambers, E.3    Qin, G.4    Losordo, D.W.5    Kishore, R.6
  • 51
    • 67249152096 scopus 로고    scopus 로고
    • Cardiac fibroblasts: at the heart of myocardial remodeling
    • COI: 1:CAS:528:DC%2BD1MXnsFyhtbY%3D, PID: 19460403
    • Porter KE, Turner NA (2009) Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 123:255–278. doi:10.1016/j.pharmthera.2009.05.002
    • (2009) Pharmacol Ther , vol.123 , pp. 255-278
    • Porter, K.E.1    Turner, N.A.2
  • 52
    • 77951151612 scopus 로고    scopus 로고
    • inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4
    • COI: 1:CAS:528:DC%2BC3cXltFSmtL0%3D, PID: 20068138
    • Arakawa M, Mita T, Azuma K, Ebato C, Goto H, Nomiyama T, Fujitani Y, Hirose T, Kawamori R, Watada H (2010) inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4. Diabetes 59:1030–1037. doi:10.2337/db09-1694
    • (2010) Diabetes , vol.59 , pp. 1030-1037
    • Arakawa, M.1    Mita, T.2    Azuma, K.3    Ebato, C.4    Goto, H.5    Nomiyama, T.6    Fujitani, Y.7    Hirose, T.8    Kawamori, R.9    Watada, H.10
  • 55
    • 7944219811 scopus 로고    scopus 로고
    • Extracellular signal regulated kinase and SMAD signalling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27
    • COI: 1:CAS:528:DC%2BD2cXotlKqu7c%3D, PID: 15322702
    • de Boer RA, Pokharel S, Flesch M, van Kampen DA, Suurmeijer AJ, Boomsma F, van Gilst WH, van Veldhuisen DJ, Pinto YM (2004) Extracellular signal regulated kinase and SMAD signalling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27. J Mol Med 82:678–687. doi:10.1007/s00109-004-0579-3
    • (2004) J Mol Med , vol.82 , pp. 678-687
    • de Boer, R.A.1    Pokharel, S.2    Flesch, M.3    van Kampen, D.A.4    Suurmeijer, A.J.5    Boomsma, F.6    van Gilst, W.H.7    van Veldhuisen, D.J.8    Pinto, Y.M.9
  • 58
    • 0034105968 scopus 로고    scopus 로고
    • TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice
    • COI: 1:CAS:528:DC%2BD3cXjtFyhtrg%3D, PID: 10802712
    • Zhang D, Gaussin V, Taffet GE, Belaguli NS, Yamada M, Schwartz RJ, Michael LH, Overbeek PA, Schneider MD (2000) TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat Med 6:556–563. doi:10.1038/75037
    • (2000) Nat Med , vol.6 , pp. 556-563
    • Zhang, D.1    Gaussin, V.2    Taffet, G.E.3    Belaguli, N.S.4    Yamada, M.5    Schwartz, R.J.6    Michael, L.H.7    Overbeek, P.A.8    Schneider, M.D.9
  • 59
    • 84911419215 scopus 로고    scopus 로고
    • Interleukin-13 deficiency aggravates healing and remodeling in male mice after experimental myocardial infarction
    • COI: 1:CAS:528:DC%2BC2cXhsFymurjJ, PID: 24970469
    • Hofmann U, Knorr S, Vogel B, Weirather J, Frey A, Ertl G, Frantz S (2014) Interleukin-13 deficiency aggravates healing and remodeling in male mice after experimental myocardial infarction. Circ Heart Fail 7:822–830. doi:10.1161/CIRCHEARTFAILURE.113.001020
    • (2014) Circ Heart Fail , vol.7 , pp. 822-830
    • Hofmann, U.1    Knorr, S.2    Vogel, B.3    Weirather, J.4    Frey, A.5    Ertl, G.6    Frantz, S.7
  • 60
    • 84908110212 scopus 로고    scopus 로고
    • Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer
    • COI: 1:CAS:528:DC%2BC2cXhsFertLnP, PID: 25200057
    • Ong SG, Lee WH, Huang M, Dey D, Kodo K, Sanchez-Freire V, Gold JD, Wu JC (2014) Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer. Circulation 130:S60–S69. doi:10.1161/CIRCULATIONAHA.113.007917
    • (2014) Circulation , vol.130 , pp. 60-69
    • Ong, S.G.1    Lee, W.H.2    Huang, M.3    Dey, D.4    Kodo, K.5    Sanchez-Freire, V.6    Gold, J.D.7    Wu, J.C.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.